BMY - Bristol-Myers Squibb

BMY trying to come up for air – The worst of the peers

Bristol Myers Squibb is a global specialty biopharmaceutical company focusing on diseases such as oncology, cardiovascular, immunoscience, and hematology. The company’s acquisition of Celgene has further strengthened its position expanding its oncology and immunoscience portfolios. About 58% of Bristol Myers’ … Read more